Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-21
1998-12-22
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514330, 514331, 514640, A01N 4342
Patent
active
058520449
ABSTRACT:
The invention relates to the use of NK.sub.1 receptor antagonists for the preparation of drugs with a cardioregulatory action, intended in particular for controlling heart rate disorders and cardiac dysrhythtmia.
REFERENCES:
patent: 5242930 (1993-09-01), Baker et al.
patent: 5554627 (1996-09-01), Lewis et al.
Novelli et al., ll Farmaco, vol. 48 No. 8, pp. 1021-1049, 1993.
Saigo et al., Regul. Pept., vol. 46, No. 1-2, pp. 293-296, 1993.
Prat et al., Br. J. Pharmacol., vol. 112, No. 1, pp. 250-256, 1994.
Delay-Goyet et al., Eur. J. Pharmacol., vol. 222, No. 2-3, pp. 213-218, 1992.
Abstract to EP 591040 HCAPLUS 1994:323276, 1994.
Gueudet Christiane
Santucci Vincent
Soubrie Philippe
Cintins Marianne M.
Jones Dwayne C.
Sanofi
LandOfFree
Use of NK.sub.1 receptor antagonists for preparing cardio-regula does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of NK.sub.1 receptor antagonists for preparing cardio-regula, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of NK.sub.1 receptor antagonists for preparing cardio-regula will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2048064